Quantcast

Latest Anti-diabetic drugs Stories

2014-12-21 23:00:57

Hundreds of Byetta lawsuits and other product liability claims involving incretin mimetic diabetes drugs are currently pending in the federal litigation underway in California. New

2014-12-10 12:28:36

DALLAS, December 10, 2014 /PRNewswire/ -- ReportsnReports.com adds Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes

2014-12-07 23:01:20

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin

2014-12-02 12:31:26

The Lack of Reimbursement for DPP-IV Inhibitors and GLP-1 Analogues Hinders Their Uptake Among Chinese Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Dec.

2014-12-01 23:00:55

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin

2014-11-23 23:01:16

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer after taking incretin

2014-11-20 12:31:06

LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe

2014-11-17 20:23:33

Expresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Nov.

2014-11-12 00:21:49

- Intarcia grants Servier exclusive rights to ITCA 650 in ex-U.S./Japan territories; Intarcia retains full control of ITCA 650 in the United States and plans another partner in Japan.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.